Biomark DiagnosticsBUX 
$0.184.35%24h
4.35%24h
Global rank31103
Market cap$14.72M
Change 7d11.63%
YTD Performance-4.00%
SP500 benchmarkUnderperform
P/E-8.89
P/S129.43
Revenue$113.75K
Earnings-$1.37M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Biomark Diagnostics (BUX)
As of August 2024, Biomark Diagnostics has a market cap of $14.72M. This makes Biomark Diagnostics the world's 31103th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Biomark Diagnostics from 2014 to 2024
-
Value:-
Market cap history of Biomark Diagnostics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $17.48M | 11.76% |
| 2023 | $15.64M | 15.91% |
| 2022 | $13.50M | -18.52% |
| 2021 | $16.56M | 80.00% |
| 2020 | $9.20M | -34.78% |
| 2019 | $14.11M | 411.11% |
| 2018 | $2.76M | -52.63% |
| 2017 | $5.83M | -20.83% |
| 2016 | $7.36M | 0.00% |
| 2015 | $7.36M | -74.47% |
| 2014 | $28.83M | - |
BUX Market Cap Today is $14.72M 4.35% - 31 Aug 2024
View largest stocks by market cap 
